HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019

2014-2019年我国南方MSM人群艾滋病耐药及遗传传播网络分析

Yun Lan et al.

Infection and drug resistance. 2021 Aug 4:14:2977-2989.

Uptake of biomedical interventions for prevention of sexually transmitted HIV

作为预防性传播的HIV的生物医学干预措施的接受度

Ume L Abbas

Current opinion in HIV and AIDS. 2011 Mar;6(2):114-8.

A meta-analysis of condom effectiveness in reducing sexually transmitted HIV

关于安全套降低性传播HIV效果的meta分析研究

D L Warner

Social science & medicine (1982). 1994 Apr;38(8):1169-70.

A meta-analysis of condom effectiveness in reducing sexually transmitted HIV

关于安全套降低性传播HIV风险有效性的荟萃分析研究进展

S C Weller

Social science & medicine (1982). 1993 Jun;36(12):1635-44.

[Mechanisms of HIV-1 drug resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors]

[HIV-1对核苷和非核苷逆转录酶抑制剂的耐药机制]

G N Nikolenko et al.

Molekuliarnaia biologiia. 2011 Jan-Feb;45(1):108-26.

Withdrawn: Prevalence of HIV-1 Drug Resistance Among HAART-Virological Failure Patients Between 2011 and 2012 in Hebei, China

河北艾滋病毒治疗失败患者中耐药性的流行率（2011-2012）[撤稿]

Reviews on recent clinical trials. 2016 Sep 2.

Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China

中国重庆市获得性和传染性整合酶链转移抑制剂相关HIV-1耐药的流行和分析

Huizheng Zhang et al.

Virulence. 2023 Dec;14(1):2278254.

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens

喀麦隆基于实验室的HIV-1获得性药物耐药监测：对替诺福韦-拉米夫定-多替拉韦(TLD)用作二三线方案的意义

Joseph Fokam et al.

Viruses. 2023 Aug 2;15(8):1683.